Endpoints News Feb 11, 2026 Upstream Bio says verekitug delivered positive data in Phase 2 severe asthma trial
Endpoints News Feb 10, 2026 Moderna accuses FDA of shifting standard as agency refuses flu shot review
Endpoints News Feb 10, 2026 AbbVie, AstraZeneca lose appeal in Louisiana 340B contract pharmacy fight
Endpoints News Feb 10, 2026 NIH stops low-dose Xarelto arm of large stroke study due to safety concerns
Endpoints News Feb 10, 2026 AstraZeneca’s obesity pill hits in Phase 2, key cancer trials pushed back
Endpoints News Feb 10, 2026 Hengrui, Kailera push obesity pill ahead on promising mid-stage China data